The computational wave of Covid has spurred the convergence of technology and science at an unprecedented pace. The outcome, which is a portfolio of vaccines and anti-viral drugs, along with online and app-based applications, illustrates the interconnection between basic science and technology. Scale and inclusivity are the hallmarks of the vaccine drive that began in January 2021. “India has administered more than 117 crore [1.17 billion] Covid vaccines under the world’s largest vaccine drive so far,” the Government of India tweeted. This could well be an example of technology facilitating mass manufacturing.
The future could be about new drugs to combat infections and decode forms of virus. All this has boosted the intrinsic value of pharma companies. We need to take it to the next level. “India has great bio-manufacturing capabilities in the world. But it requires high capital investment. Production-linked incentive (PLI) is essential for bio pharma...